Silicon Republic February 22, 2024
Leigh Mc Gowran

The US agency said smartwatches and smart rings that claim to measure blood glucose without piercing the skin are not FDA approved and could cause people with diabetes to mismanage their condition.

Wearables such as smartwatches are commonly associated with health monitoring, but the US Food and Drug Administration (FDA) has issued a warning about a particular feature being advertised by some devices.

The FDA warned against using smartwatches or smart rings that claim to measure blood glucose levels – or blood sugar – without piercing the skin.

Regularly monitoring blood sugar levels is important for people with diabetes to manage the condition. The World Health Organization estimates that more than 422m people live with diabetes globally.

Smartwatches have been...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, FDA, Govt Agencies, Technology, Wearables
Wearable Health Tech: Innovations and Impacts on Chronic Disease Management
Driving Urgent Change To Optimize The Patient Experience
Sibionics Blood Glucose Sensor: Review
Dexcom invests $75M in Ōura, agrees to integrate smart rings and CGMs
Wearable Device Can Warn of Worsening Heart Failure

Share This Article